(NGVT) Ingevity - Ratings and Ratios
Activated Carbon, Pavement Additives, Cyanide Regeneration, Oilfield Products
NGVT EPS (Earnings per Share)
NGVT Revenue
Description: NGVT Ingevity
Ingevity Corp (NYSE:NGVT) is a US-based specialty chemicals company. The firms quarterly tax provision data is being analyzed, likely to gauge the impact of tax-related expenses on its financials.
To better understand NGVTs performance, key performance indicators (KPIs) such as revenue growth, gross margin, and operating cash flow should be examined. A high gross margin could indicate a competitive advantage, while a strong operating cash flow would suggest the companys ability to generate liquidity.
The specialty chemicals industry is driven by factors like demand from end-markets (e.g., automotive, construction), raw material prices, and global economic trends. NGVTs performance is likely tied to the performance of its key end-markets, such as the automotive industry, where it may supply products like activated carbon and other specialty chemicals.
Economic drivers that could impact NGVTs stock include GDP growth, interest rates, and commodity prices. A rising GDP could boost demand for NGVTs products, while an increase in interest rates might strengthen the US dollar, potentially affecting the companys exports.
From a valuation perspective, NGVTs forward P/E ratio of 9.97 suggests the market expects the company to generate earnings in the future. However, the current P/E ratio is not available, and the Return on Equity (RoE) is negative, indicating that the company has experienced significant losses. A thorough analysis of the companys financial statements and industry trends is necessary to understand the underlying drivers of these metrics.
To make an informed investment decision, it is essential to assess NGVTs competitive position, product portfolio, and growth prospects. This includes evaluating the companys ability to innovate, its cost structure, and its capacity to navigate industry disruptions.
NGVT Stock Overview
| Market Cap in USD | 2,074m |
| Sub-Industry | Specialty Chemicals |
| IPO / Inception | 2016-05-02 |
NGVT Stock Ratings
| Growth Rating | 6.11% |
| Fundamental | 24.9% |
| Dividend Rating | - |
| Return 12m vs S&P 500 | 26.5% |
| Analyst Rating | 4.0 of 5 |
NGVT Dividends
Currently no dividends paidNGVT Growth Ratios
| Growth Correlation 3m | 79.4% |
| Growth Correlation 12m | 36.4% |
| Growth Correlation 5y | -76.4% |
| CAGR 5y | 0.78% |
| CAGR/Max DD 5y | 0.01 |
| Sharpe Ratio 12m | 0.23 |
| Alpha | 25.30 |
| Beta | 1.668 |
| Volatility | 40.05% |
| Current Volume | 207.6k |
| Average Volume 20d | 294k |
| Stop Loss | 56.6 (-3%) |
| Signal | 0.34 |
Piotroski VR‑10 (Strict, 0-10) 4.5
| Net Income (-216.6m TTM) > 0 and > 6% of Revenue (6% = 79.5m TTM) |
| FCFTA 0.08 (>2.0%) and ΔFCFTA 4.85pp (YES ≥ +1.0pp, WARN ≥ +0.5pp) |
| NWC/Revenue 7.36% (prev 21.18%; Δ -13.82pp) (YES ≤20% & Δ≤-1pp; WARN ≤25% & Δ≤0 oder ≤40% & Δ≤-3pp) |
| CFO/TA 0.11 (>3.0%) and CFO 215.4m > Net Income -216.6m (YES >=105%, WARN >=100%) |
| NO Net Debt/EBITDA fails (EBITDA <= 0) |
| Current Ratio 1.25 (target 1.5–3.0; WARN 1.2–<1.5 or >3.0–5.0; CFO/TA gate active) |
| Outstanding Shares last Quarter (36.4m) change vs 12m ago 0.18% (target <= -2.0% for YES) |
| Gross Margin 36.47% (prev 25.91%; Δ 10.56pp) >=18% & Δ>=+0.5pp (WARN >=15% & Δ>=0) |
| Asset Turnover 63.79% (prev 68.03%; Δ -4.24pp) >=50% & Δ>=+2pp (WARN >=35% & Δ>=0) |
| Interest Coverage Ratio -1.80 (EBITDA TTM -106.6m / Interest Expense TTM 88.0m) >= 6 (WARN >= 3) |
Altman Z'' 0.87
| (A) 0.05 = (Total Current Assets 490.6m - Total Current Liabilities 393.1m) / Total Assets 1.88b |
| (B) 0.24 = Retained Earnings (Balance) 446.0m / Total Assets 1.88b |
| (C) -0.08 = EBIT TTM -158.0m / Avg Total Assets 2.08b |
| (D) 0.25 = Book Value of Equity 446.0m / Total Liabilities 1.76b |
| Total Rating: 0.87 = (6.56 * A) + (3.26 * B) + (6.72 * C) + (1.05 * D) |
ValueRay F-Score (Strict, 0-100) 24.89
| 1. Piotroski 4.50pt = -0.50 |
| 2. FCF Yield 3.29% = 1.65 |
| 3. FCF Margin 11.35% = 2.84 |
| 4. Debt/Equity 21.26 = -2.50 |
| 5. Debt/Ebitda -24.07 = -2.50 |
| 6. ROIC - WACC -15.62% = -12.50 |
| 7. RoE -113.3% = -2.50 |
| 8. Rev. Trend -71.96% = -3.60 |
| 9. Rev. CAGR -9.61% = -1.60 |
| 10. EPS Trend -55.90% = -1.40 |
| 11. EPS CAGR -66.08% = -2.50 |
What is the price of NGVT shares?
Over the past week, the price has changed by +1.02%, over one month by +32.41%, over three months by +36.37% and over the past year by +47.91%.
Is Ingevity a good stock to buy?
Based on momentum, paid dividends and discounted-cash-flow analyses, the fair value of NGVT is around 60.46 USD . This means that NGVT is currently overvalued and has a potential downside of 3.56%.
Is NGVT a buy, sell or hold?
- Strong Buy: 1
- Buy: 2
- Hold: 1
- Sell: 0
- Strong Sell: 0
What are the forecasts/targets for the NGVT price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 60.5 | 3.6% |
| Analysts Target Price | 60.5 | 3.6% |
| ValueRay Target Price | 65.7 | 12.6% |
Last update: 2025-08-27 04:44
NGVT Fundamental Data Overview
CCE Cash And Equivalents = 76.9m USD (Cash And Short Term Investments, last quarter)
P/E Forward = 9.9701
P/S = 1.5654
P/B = 17.1818
P/EG = 2.05
Beta = 1.368
Revenue TTM = 1.32b USD
EBIT TTM = -158.0m USD
EBITDA TTM = -106.6m USD
Long Term Debt = 1.24b USD (from longTermDebt, last quarter)
Short Term Debt = 1.33b USD (from shortTermDebt, last quarter)
Debt = 2.57b USD (Calculated: Short Term 1.33b + Long Term 1.24b)
Net Debt = 1.25b USD (from netDebt column, last quarter)
Enterprise Value = 4.56b USD (2.07b + Debt 2.57b - CCE 76.9m)
Interest Coverage Ratio = -1.80 (Ebit TTM -158.0m / Interest Expense TTM 88.0m)
FCF Yield = 3.29% (FCF TTM 150.3m / Enterprise Value 4.56b)
FCF Margin = 11.35% (FCF TTM 150.3m / Revenue TTM 1.32b)
Net Margin = -16.35% (Net Income TTM -216.6m / Revenue TTM 1.32b)
Gross Margin = 36.47% ((Revenue TTM 1.32b - Cost of Revenue TTM 841.7m) / Revenue TTM)
Tobins Q-Ratio = 10.23 (Enterprise Value 4.56b / Book Value Of Equity 446.0m)
Interest Expense / Debt = 0.67% (Interest Expense 17.2m / Debt 2.57b)
Taxrate = 21.0% (US default)
NOPAT = -158.0m (EBIT -158.0m, no tax applied on loss)
Current Ratio = 1.25 (Total Current Assets 490.6m / Total Current Liabilities 393.1m)
Debt / Equity = 21.26 (Debt 2.57b / last Quarter total Stockholder Equity 120.7m)
Debt / EBITDA = -24.07 (Net Debt 1.25b / EBITDA -106.6m)
Debt / FCF = 17.07 (Debt 2.57b / FCF TTM 150.3m)
Total Stockholder Equity = 191.2m (last 4 quarters mean)
RoA = -11.54% (Net Income -216.6m, Total Assets 1.88b )
RoE = -113.3% (Net Income TTM -216.6m / Total Stockholder Equity 191.2m)
RoCE = -11.07% (Ebit -158.0m / (Equity 191.2m + L.T.Debt 1.24b))
RoIC = -9.89% (NOPAT -158.0m / Invested Capital 1.60b)
WACC = 5.73% (E(2.07b)/V(4.64b) * Re(12.16%)) + (D(2.57b)/V(4.64b) * Rd(0.67%) * (1-Tc(0.21)))
Shares Correlation 5-Years: -70.0 | Cagr: -2.08%
Discount Rate = 12.16% (= CAPM, Blume Beta Adj.)
[DCF Debug] Terminal Value 56.25% ; FCFE base≈118.9m ; Y1≈83.4m ; Y5≈43.6m
Fair Price DCF = 13.46 (DCF Value 490.7m / Shares Outstanding 36.5m; 5y FCF grow -35.01% → 3.0% )
Revenue Correlation: -71.96 | Revenue CAGR: -9.61%
Rev Growth-of-Growth: -4.06
EPS Correlation: -55.90 | EPS CAGR: -66.08%
EPS Growth-of-Growth: 205.8
Additional Sources for NGVT Stock
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle